Research suggests that rare germline structural variants may increase the risk of pediatric solid tumors. Studies have investigated the impact of inherited genome instability on childhood cancers, including central nervous system tumors and acute lymphoblastic leukemia. The findings may have implications for the diagnosis and treatment of pediatric cancers, with whole genome and transcriptome analyses potentially guiding clinical care.